Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma

Vox Sanguinis

Volumn 95, Issue 1, 2008, Pages 70-75

  Bojanic, I ^a   Cepulic, B Golubic ^a   Mazic, S ^a   Batinic, D ^a   Nemet, D ^a   Labar, B ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Adverse reactions; Autologous PBPC infusion; Granulocytes; Multiple myeloma

Indexed keywords

DIMETHYL SULFOXIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LIQUID NITROGEN;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY; FEMALE; GRANULOCYTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

GRANULOCYTES; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MULTIPLE MYELOMA; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 44849084103     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01060.x     Document Type: Article

References (13)

1. Bakken AM:Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006 1:47 54
2. Sauer-Heilborn A, Kadidlo D, McCullough J:Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004 44:907 916
3. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T EBMT Chronic Leukaemia Working Party Complications Subcommittee:Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005 36:601 603
4. National Cancer Institute:National Cancer Institute Common Toxicity Criteria Classification, version 2 available at http://ctep.cancer.gov/forms/ CTCv20_4-30-992.pdf.
5. Smalcelj R, Kusec V, Thune S, Petrovecki M:Circulating hematopoietic progenitors are not altered in patients with post-transplant erythrocytosis. Haematologica 1998 83:948 949
6. Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C:Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007 47:1268 1275
7. Rowley SD, Feng Z, Yadock D, Holmberg L, MacLeod B, Heimfeld S:Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy 1999 6:439 446
8. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P:Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996 81:59 61
9. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R:Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007 9:348 355
10. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G:Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18:4705 4708
11. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S:Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007 36:95 101
12. Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B:Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002 29:544
13. Del Fante C, Perotti C, Viarengo G, Bellotti L, Parisi C, Marchesi A, Tinelli C, Salvaneschi L:Clinical impact of a new automated system employed for peripheral blood stem cell collection. J Clin Apher 2006 21:227 232